Optimizing correction of coma aberration in keratoconus with a novel soft contact lens.


Journal

Contact lens & anterior eye : the journal of the British Contact Lens Association
ISSN: 1476-5411
Titre abrégé: Cont Lens Anterior Eye
Pays: England
ID NLM: 9712714

Informations de publication

Date de publication:
Aug 2021
Historique:
received: 02 06 2020
revised: 29 12 2020
accepted: 31 12 2020
pubmed: 14 1 2021
medline: 1 9 2021
entrez: 13 1 2021
Statut: ppublish

Résumé

To report on a second-generation prototype contact lens (modified lens) with enhanced optics to correct coma aberration and compare its performance with that of the prototype contact lens (conventional lens) used to optimise correction of coma aberration in keratoconus (KC). Both lenses were designed as a set of standardised soft contact lenses (SCLs) with asymmetric powers along the posterior surface. The modified lens differs from the conventional lens in that the optical zone is decentred superiorly by 0.7 mm. The on-eye performance was compared between the SCLs and no-lens wearing in terms of manifest refraction, corrected distance visual acuity (CDVA), ocular aberrations, subjective quality of vision, and on-eye lens position relative to the pupil. Thirty-four KC eyes were included. SCLs significantly decreased coma aberration compared to no-lens wear (none, 0.68 ± 0.27 μm; conventional lens, 0.37 ± 0.28 μm; modified lens, 0.19 ± 0.15 μm; P < 0.001), with the reduction in coma aberration being significantly greater with the modified lens than with the conventional lens (P = 0.018). No significant difference in manifest refraction or CDVA was found among the three conditions. Quality of vision was significantly better with the modified lens than with no SCL wear (P < 0.05) but no differences were found between the SCLs. The on-eye optical center position relative to the pupil was closer to the pupil centre using the modified lens than the conventional lens (P < 0.001). Optimisation of the location of the optical zone in a standardised asymmetric SCL improves correction of coma aberrations and on-eye optical centration.

Identifiants

pubmed: 33436159
pii: S1367-0484(21)00004-7
doi: 10.1016/j.clae.2020.12.071
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

101405

Informations de copyright

Copyright © 2021 British Contact Lens Association. Published by Elsevier Ltd. All rights reserved.

Auteurs

Asaki Suzaki (A)

Department of Applied Visual Science, Osaka University Graduate School of Medicine, Osaka, Japan; Global R&D, Menicon Co., Ltd., Nagoya, Japan. Electronic address: a-suzaki@menicon.co.jp.

Shizuka Koh (S)

Department of Innovative Visual Science, Osaka University Graduate School of Medicine, Osaka, Japan; Department of Ophthalmology, Osaka University Graduate School of Medicine, Osaka, Japan. Electronic address: skoh@ophthal.med.osaka-u.ac.jp.

Naoyuki Maeda (N)

Department of Ophthalmology, Osaka University Graduate School of Medicine, Osaka, Japan. Electronic address: nmaeda@ophthal.med.osaka-u.ac.jp.

Sanae Asonuma (S)

Department of Ophthalmology, Osaka University Graduate School of Medicine, Osaka, Japan. Electronic address: asonuma@ophthal.med.osaka-u.ac.jp.

Jacinto Santodomingo-Rubido (J)

Global R&D, Menicon Co., Ltd., Nagoya, Japan. Electronic address: j.santodomingo@menicon.com.

Yoshinori Oie (Y)

Department of Ophthalmology, Osaka University Graduate School of Medicine, Osaka, Japan. Electronic address: yoie@ophthal.med.osaka-u.ac.jp.

Takeshi Soma (T)

Department of Ophthalmology, Osaka University Graduate School of Medicine, Osaka, Japan. Electronic address: soma@ophthal.med.osaka-u.ac.jp.

Takashi Fujikado (T)

Department of Applied Visual Science, Osaka University Graduate School of Medicine, Osaka, Japan. Electronic address: fujikado@ophthal.med.osaka-u.ac.jp.

Kohji Nishida (K)

Department of Ophthalmology, Osaka University Graduate School of Medicine, Osaka, Japan. Electronic address: knishida@ophthal.med.osaka-u.ac.jp.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH